Featured in Hidradenitis Suppurativa
Earlier Treatment, Different Outcomes: Secukinumab and the HS Disease Course
Discover this week's featured video and expert opinion
Latest Hidradenitis Suppurativa Videos
Hidradenitis Suppurativa
WCM26 Day 2 Video Recap
Featuring James Del Rosso, DO | Andrea Murina, MD | Shawn Kwatra, MD | Dawn Merritt, DO
Hidradenitis Suppurativa
What Four Years Can Tell Us About Treating Moderate to Severe HS
Featuring Nicholas Brownstone, MD
Featured CME on Hidradenitis Suppurativa
Hidradenitis Suppurativa Episodes to Explore
Episode 2
Another Cup of Tea with Dr. D? Part 2: Closing the Loop on HS
In Part Two of the Tea with Dr. D premiere, James Q. Del Rosso, DO, returns with Lauren Lam, MD, a Canadian dermatologist...
Episode 1
Solving The Puzzle of Hidradenitis Suppurativa: Pulling All the Pieces Together for Each Patient
In this premiere episode of Tea with Dr. D, James Q. Del Rosso, DO, welcomes Lauren Lam, MD, a Canadian dermatologist with...
Hidradenitis Suppurativa News & Research
Patients With Hidradenitis Suppurativa Have Increased Risk for Self-Harm
Patients with HS have a higher hazard of suicide; those who die by suicide more often have prior self-harm episodes
Four-Year Efficacy and Safety Of Continuous Secukinumab in HS: SUNSHINE/SUNRISE Core and Extension Trials
Sponsored by Novartis Medical Affairs | December 30, 2025
DISCLAIMER: The content provided herein is for your background and educational purposes only and may...
Early Treatment Initiation With Secukinumab: Insights From the SUNSHINE/SUNRISE Core Trials
Sponsored by Novartis Medical Affairs | December 30, 2025
LIMITATIONS: The analyses for this poster were exploratory, and no statistical testing was applied.
DISCLAIMER:...